Antihemophilic Factor (Recombinant) (Afstyla) and Dihydroergotamine injection
Determining the interaction of Antihemophilic Factor (Recombinant) (Afstyla) and Dihydroergotamine injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant) (Afstyla)-Dihydroergotamine Mesylate
- Antihemophilic Factor (Recombinant) (Afstyla)-Dihydroergotamine nasal
- Antihemophilic Factor (Recombinant) (Afstyla)-Dihydroergotamine Nasal Spray
- Antihemophilic Factor (Recombinant) (Afstyla)-Dilacor XR
- Antihemophilic Factor (Recombinant) (Afstyla)-Dilantin
- Antihemophilic Factor (Recombinant) (Afstyla)-Dilantin Infatabs
- Dihydroergotamine injection-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)
- Dihydroergotamine injection-Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)
- Dihydroergotamine injection-Antihemophilic Factor (Recombinant) (Nuwiq)
- Dihydroergotamine injection-Antihemophilic Factor (Recombinant) (Recombinate)
- Dihydroergotamine injection-Antihemophilic Factor (Recombinant) (Xyntha)
- Dihydroergotamine injection-Antihemophilic factor (recombinant) pegylated-aucl Intravenous